Home › Glioblastoma › NCT07664579
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Have received a diagnosis of a primary brain tumor (glioblastoma), or other cancers (breast, lung, etc.) * Are new patients to City of Hope (COH) (all sites) or receive at least some of their care at City of Hope- Duarte Campus (care is defined as: procedures, consults, laboratories, imaging, surgery, and/or treatment) * The patient is in a committed relationship/partnership with a partner and the partner is available and willing to participate * Are English or Spanish speaking * ≥ 18 years of age * Have access to a smartphone, computer/laptop or internet connection to complete all study procedures Exclusion Criteria: * Significant cognitive impairment * Inpatient psychiatric treatment for severe mental illness or overt signs of severe psychopathology (e.g., psychosis) * Visual, hearing, voice, or motor impairment that prevents completion of study procedures as evidenced by clinical judgment * Committed partners will be excluded from the study if they: * Refuse to complete informed consent * Have cognitive impairment * Have severe mental illness that would prevent informed consent and completion of study activities as evidenced by clinical judgment
About the study
This study evaluates how useful and acceptable the components of the "Couples Coping Together Against Cancer", referred to as "The Program", are to the participants with cancer.
What is being tested
- Non-Interventional Study (other)
Sponsor: City of Hope Medical Center · Participants: 160 · Started: Jul 5, 2024
Contact the study team
Official record on ClinicalTrials.gov — NCT07664579
Locations in the U.S.
| California | City of Hope Medical Center, Duarte |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.